2024
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
Bang A, Fay C, LeBoeuf N, Etaee F, Leventhal J, Sibaud V, Arbesman J, Wang J, Kwong B. Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors. Breast Cancer Research And Treatment 2024, 204: 643-647. PMID: 38224427, DOI: 10.1007/s10549-023-07217-2.Peer-Reviewed Original ResearchVitiligo-like lesionsProgression-free survivalSurvival benefitMedian progression-free survivalAssociated with survival benefitSkin-directed therapiesMetastatic breast cancerSun-exposed areasPotential treatment optionCyclin-dependent kinase 4ConclusionClinical characteristicsMild repigmentationRuxolitinib creamTopical ruxolitinibMethodsRetrospective reviewResultsMedian ageClinical characteristicsCase reportTreatment optionsBreast cancerKinase inhibitorsCDK4/6iInternational cohortPatientsQuality of life
2022
Stenotrophomonas maltophilia, a Pathogen of Increasing Relevance to Dermatologists: A Case Report and Review of the Literature
Belzer A, Weiss E, Etaee F, Bunick CG, Damsky W, Nelson CA. Stenotrophomonas maltophilia, a Pathogen of Increasing Relevance to Dermatologists: A Case Report and Review of the Literature. Antibiotics 2022, 11: 1398. PMID: 36290055, PMCID: PMC9598652, DOI: 10.3390/antibiotics11101398.Peer-Reviewed Original ResearchSoft tissue infectionsUrinary tract infectionChronic lymphocytic leukemiaGram-negative bacilliTract infectionsImmunocompetent populationTissue infectionsHigh morbidityAplastic anemiaCase reportLymphocytic leukemiaInfectionBacteremiaCurrent standardStenotrophomonas maltophiliaDermatologistsLimited optionsMorbidityPneumoniaPatientsAnemiaTherapyLeukemiaMortalityPrevalenceErythema multiforme in COVID‐19 patients and following COVID‐19 vaccination: manifestations, associations and outcomes
Etaee F, Eftekharian M, Naguib T, Daveluy S. Erythema multiforme in COVID‐19 patients and following COVID‐19 vaccination: manifestations, associations and outcomes. Journal Of The European Academy Of Dermatology And Venereology 2022, 36: e524-e530. PMID: 35274375, PMCID: PMC9114911, DOI: 10.1111/jdv.18063.Peer-Reviewed Original Research
2021
Comparison of patient satisfaction with diode laser treatment of female hirsutism: low fluence or high fluence?
Ardakani M, Azad M, Ghanei N, Etaee F, Naguib T, Daveluy S. Comparison of patient satisfaction with diode laser treatment of female hirsutism: low fluence or high fluence? Journal Of Cosmetic And Laser Therapy 2021, 23: 113-115. PMID: 34763585, DOI: 10.1080/14764172.2021.2001533.Peer-Reviewed Original ResearchConceptsPatient satisfactionLaser therapySide effectsRate of complicationsEnd of treatmentGreater patient satisfactionCross-sectional studyDiode laser treatmentLaser treatmentFirst sessionTreatment courseMedical recordsFemale hirsutismTreatment sessionsSatisfaction ratePatientsTherapy techniquesHirsutismComplicationsTreatmentTherapySatisfaction levelMonthsLaser CenterSessions
2020
Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis
Elayi C, Shohoudi A, Moodie E, Etaee F, Guglin M, Roy D, Khairy P, Investigators A. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis. International Journal Of Cardiology 2020, 313: 48-54. PMID: 32320783, DOI: 10.1016/j.ijcard.2020.04.047.Peer-Reviewed Original ResearchConceptsReduced ejection fractionAtrial fibrillationCardiovascular hospitalizationEjection fractionImpact of digoxinArrhythmic deathHazard ratioHeart failureCongestive Heart Failure trialAF-CHF trialsHeart Failure TrialSafety of digoxinSubgroup of patientsMarginal structural modelingCardiovascular causesCause mortalityCardiac hospitalizationSecondary outcomesFailure TrialClinical benefitHospitalizationPatientsDigoxinFibrillationOne-yearDIFFERENCES BETWEEN PATIENTS WITH INTERMITTENT CLAUDICATION AND CRITICAL LIMB ISCHEMIA UNDERGOING ENDOVASCULAR INTERVENTION
Patel K, Etaee F, Liu Y, Patel C, Banerjee A, Tejani I, Brilakis E, Banerjee S. DIFFERENCES BETWEEN PATIENTS WITH INTERMITTENT CLAUDICATION AND CRITICAL LIMB ISCHEMIA UNDERGOING ENDOVASCULAR INTERVENTION. Journal Of The American College Of Cardiology 2020, 75: 2221. DOI: 10.1016/s0735-1097(20)32848-5.Peer-Reviewed Original ResearchRandomized trial comparing the effectiveness of internal (through implantable cardioverter defibrillator) versus external cardioversion of atrial fibrillation
Elayi C, Parrott K, Etaee F, Shah J, Leung S, Guglin M, Elayi E, Jessinger M, Ogunbayo G, Catanzaro J, Morales G, Darrat Y. Randomized trial comparing the effectiveness of internal (through implantable cardioverter defibrillator) versus external cardioversion of atrial fibrillation. Journal Of Interventional Cardiac Electrophysiology 2020, 58: 261-267. PMID: 31927665, DOI: 10.1007/s10840-019-00689-7.Peer-Reviewed Original ResearchConceptsExternal direct current cardioversionImplantable cardioverter defibrillatorSymptomatic atrial fibrillationDirect current cardioversionAtrial fibrillationCardioversion groupPrimary endpointCurrent cardioversionInternal cardioversionBiventricular implantable cardioverter defibrillatorBaseline clinical characteristicsResultsThirty-one patientsNon-ischemic cardiomyopathyConclusionAmong patientsClinical characteristicsFirst shockConsecutive patientsExternal cardioversionMean ageSinus rhythmCardioverter defibrillatorCardioversionPatientsSignificant differencesFibrillation
2019
Gender differences in management of patients undergoing catheter ablation of atrioventricular nodal reentry tachycardia
Musa T, Darrat Y, Etaee F, Butt M, Czarapata M, McMullen C, Mattingly L, Daoud A, Coy K, Ogunbayo G, Delisle B, Elayi C. Gender differences in management of patients undergoing catheter ablation of atrioventricular nodal reentry tachycardia. Pacing And Clinical Electrophysiology 2019, 42: 937-941. PMID: 31144316, DOI: 10.1111/pace.13735.Peer-Reviewed Original ResearchConceptsAtrioventricular nodal reentrant tachycardiaCatheter ablationSupraventricular tachycardiaAVNRT patientsSymptom onsetSVT diagnosisAtrioventricular nodal reentry tachycardiaInitial symptom onsetManagement of patientsNodal reentrant tachycardiaNodal reentry tachycardiaGender-related disparitiesGender differencesAVNRT diagnosisCardiac testsMedian timeClinical parametersEmergency departmentReentrant tachycardiaInclusion criteriaReentry tachycardiaAppropriate carePatientsClinical decisionLarger studyContemporary practice pattern of permanent pacing for conduction disorders in inferior ST‐elevation myocardial infarction
Misumida N, Ogunbayo G, Catanzaro J, Etaee F, Kim S, Abdel‐Latif A, Ziada K, Elayi C. Contemporary practice pattern of permanent pacing for conduction disorders in inferior ST‐elevation myocardial infarction. Clinical Cardiology 2019, 42: 728-734. PMID: 31173380, PMCID: PMC6671775, DOI: 10.1002/clc.23210.Peer-Reviewed Original ResearchConceptsST-elevation myocardial infarctionHigh-degree AV blockInferior ST-elevation myocardial infarctionSinoatrial node dysfunctionPermanent pacemaker implantationPacemaker implantationConduction disordersComplete AV blockAV blockContemporary practice patternsPermanent pacemakerMyocardial infarctionPractice patternsNational Inpatient Sample databaseSecond-degree AV blockAtrioventricular conduction disordersOptimal waiting periodMobitz type II second-degree AV blockInferior myocardial infarctionHospital mortalityMedian intervalPermanent pacingPrimary diagnosisPatientsSinoatrial node